![Jonathan Finn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 22 515 $ al 30/06/2026
Jonathan Frederick Finn is currently Independent Director at Atossa Therapeutics, Inc. since 2023.
Mr. Finn is also Director at Solör Bioenergi Holding AB, Verigraft AB, and eReceivables Inc. Mr. Finn serves as Executive Vice President & CIO at Vantage Consulting Group, Inc. since 1995.
Mr. Finn is General Partner at Scientia Ventures LLC since 2006.
Former positions include Director at Rose Pharma A and Director at Solør Bioenergi Holding AS.
Education includes undergraduate studies at the University of Virginia.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 12/05/2026 | 11.666 ( 0,12 % ) | 22 515 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ATOSSA THERAPEUTICS, INC. | Director/Miembro de la Junta | 08/11/2023 |
Solör Bioenergi Holding AB
 Solör Bioenergi Holding AB Electric UtilitiesUtilities Produces and distributes district heating, steam & electricity | Inversor de Capital Privado | - |
Vantage Consulting Group, Inc.
 Vantage Consulting Group, Inc. Investment ManagersFinance Vantage strives to deliver a comprehensive, bespoke investment solution firmly grounded in fundamental investment principles. At the core of this solution lies an investment strategy meticulously tailored to their clients’ unique investment objectives, risk tolerances, diversification preferences, and their specific liquidity needs and investment horizons. | Director de Inversiones | 01/06/1995 |
Scientia Ventures LLC
 Scientia Ventures LLC Investment ManagersFinance Scientia Ventures invests in companies located in the United States. The firm focuses on companies operating in the fields of computational biology and chemistry, the digitization of medicine, and digital therapies as well as traditional drug development companies at the cutting edge of the life sciences. It participates in early stage transactions. | Director de Inversiones | 01/01/2006 |
ERECEIVABLES INC.
 ERECEIVABLES INC. Information Technology ServicesTechnology Services Provides information technology services that simplified the handling of insurance claims appeals | Inversor de Capital Privado | - |
Verigraft
 Verigraft BiotechnologyHealth Technology Engages in development of personalized human tissues for transplantation | Director/Miembro de la Junta | - |
| Empresas | Cargo | Fin |
|---|---|---|
Rose Pharma A/S
 Rose Pharma A/S Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products for treatment of pain in connection with irritable bowel syndrome | Inversor de Capital Privado | - |
Solør Bioenergi Holding AS
 Solør Bioenergi Holding AS Electric UtilitiesUtilities Produces, distributes and sells wood-based bioenergy | Inversor de Capital Privado | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 9 |
|---|---|
Atossa Therapeutics, Inc.
 Atossa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics and delivery methods for the treatment of breast cancer & other breast conditions | Health Technology |
University of Virginia
 University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rose Pharma A/S
Rose Pharma A/S Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products for treatment of pain in connection with irritable bowel syndrome | Health Technology |
Vantage Consulting Group, Inc.
Vantage Consulting Group, Inc. Investment ManagersFinance Vantage strives to deliver a comprehensive, bespoke investment solution firmly grounded in fundamental investment principles. At the core of this solution lies an investment strategy meticulously tailored to their clients’ unique investment objectives, risk tolerances, diversification preferences, and their specific liquidity needs and investment horizons. | Finance |
Solør Bioenergi Holding AS
Solør Bioenergi Holding AS Electric UtilitiesUtilities Produces, distributes and sells wood-based bioenergy | Utilities |
Solör Bioenergi Holding AB
Solör Bioenergi Holding AB Electric UtilitiesUtilities Produces and distributes district heating, steam & electricity | Utilities |
Scientia Ventures LLC
Scientia Ventures LLC Investment ManagersFinance Scientia Ventures invests in companies located in the United States. The firm focuses on companies operating in the fields of computational biology and chemistry, the digitization of medicine, and digital therapies as well as traditional drug development companies at the cutting edge of the life sciences. It participates in early stage transactions. | Finance |
Verigraft
Verigraft BiotechnologyHealth Technology Engages in development of personalized human tissues for transplantation | Health Technology |
ERECEIVABLES INC.
ERECEIVABLES INC. Information Technology ServicesTechnology Services Provides information technology services that simplified the handling of insurance claims appeals | Technology Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
